With IDdb the keystone of your research and competitive intelligence activities, you already know the benefits of using Thomson Reuters as your information partner. Trusted, expert, business-critical data delivered the moment you need it.

But what of the rest of your organization? What if you had a single data super-silo that delivers drug and market awareness to all your departments — from clinical trials to licensing — in an intuitive, user-friendly interface, with sophisticated cross-linking, indexing and collaboration tools, and enriched with unique value-added abstracts and analysis?

Thomson Pharma equips your users to work faster, smarter, and to explore innovative new directions.

Its "joined up thinking" not only encompasses your entire drugs pipeline, but gives you the edge to get and stay ahead of your competitors.

And with only one contract, one invoice, one set of user passwords and one system to learn, you can concentrate on growing your business, not running it.

More ways to access, analyze and share information

The breadth of information available to you through Thomson Pharma can revolutionize your organization — fully integrated, up-to-the-minute content covering drugs, targets, chemical and biological data, gene sequences, patents, competitor activity, licensing opportunities, and the latest news stories and journal articles.

But youll never be overwhelmed. Its unique customizable "portlets" enable your users to open and close windows of information relevant to their job specialty or therapy area.

You can explore the latest updates at the click of a mouse, or have Thomson Pharma automatically alert you when they arrive.

Searches are easier and more powerful than in IDdb. You can merge, compare, rank and analyze your results, then save or export them to BizInt, Excel and Word.

More ways to achieve more

• Complementary data from 40 Thomson Reuters sources including DrugDex, NewsEdge, SDdb, MedStat, WDI, Dolphin and DWPI
• Drugs SWOT analysis (not in IDdb)
• Coverage of launched drugs (not in IDdb) including sales and market share, prescription metrics,cautions and pharmacokinetics
• Patent info from over 40 authorities (IDdb covers just 5) with full text, value-added abstract and commentary, a unique first glance overview, legal status, SPC expiry dates, and relevant patent family information
• Chemistry data (not in IDdb) compiling structure information from patents and journals, enabling you to ensure your research is unique
• Deeper competitive intelligence including sales and market share, financial analysis, share performance, balance sheets, forecasted sales, collaborations and licensing deals
• Greater coverage of press releases, conferences, company websites, reports and the literature (drawn from more than 11,000 pharmaceutical, life sciences and chemical journals) with Biosis and Mesh indexing and WoS citing/cited references
• Target information (not in IDdb) enabling you to study the function and taxonomy of a target, how many drugs act on it, and their stages of development

Where next? Chemistry and biology searchers